Home Cart Sign in  
Chemical Structure| 66280-25-9 Chemical Structure| 66280-25-9

Structure of Gomisin J
CAS No.: 66280-25-9

Chemical Structure| 66280-25-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Gomisin J is a natural product isolated and purified from the fruits of Schizandra chinensis with vasodilatory activity that mediates mainly by calcium-dependent activation of eNOS with subsequent production of endothelial NO, and inhibits LPO in rat liver mitochondria and protects cultured myocardial cells from being injured by calcium paradox.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Gomisin J

CAS No. :66280-25-9
Formula : C22H28O6
M.W : 388.45
SMILES Code : OC1=C(OC)C(OC)=C(C2=C(OC)C(OC)=C(O)C=C2C[C@H](C)[C@H](C)C3)C3=C1
MDL No. :MFCD29048562
InChI Key :PICOUNAPKDEPCA-TXEJJXNPSA-N
Pubchem ID :3001686

Safety of Gomisin J

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Gomisin J

epigenetics
PI3K-AKT

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
recombinant human UGT1A9 100 μM inhibited UGT1A9 activity by 93.1% Phytother Res. 2015 Oct;29(10):1658-64
recombinant human UGT1A1 100 μM inhibited UGT1A1 activity by 91.8% Phytother Res. 2015 Oct;29(10):1658-64
THP-1™NF-κB cells 10 µM 1 hour Evaluate antioxidant activity via CAA assay. Results showed Gomisin J exhibited moderate antioxidant activity. Int J Mol Sci. 2024 Mar 19;25(6):3465

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Wistar rats Middle cerebral artery occlusion/reperfusion (MCAO/R) model Intraperitoneal injection 5, 10, 20, 40, and 80 mg/kg Single dose before reperfusion GJ alleviated neuronal injury in I/R rats, reduced neurological scores, cerebral infarction, and brain water content, inhibited apoptosis of hippocampal neurons, increased the expression of anti-apoptotic protein Bcl-XL, decreased the levels of cleaved caspase-3, Bax, COX-2, NF-κB, and NO, enhanced Nrf2 nuclear translocation, HO-1 expression, SOD and GSH-Px activities, and GSH level, and reduced lipid peroxidation. Bioengineered. 2022 Mar;13(3):6908-6918

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.57mL

0.51mL

0.26mL

12.87mL

2.57mL

1.29mL

25.74mL

5.15mL

2.57mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories